Richard H Himes

Title: Richard H Himes: Innovator in Neuroprotective Agents

Introduction

Richard H Himes is a notable inventor based in Lawrence, KS (US). He has made significant contributions to the field of neuroprotective agents, showcasing his expertise and innovative spirit. His work focuses on developing novel compounds that exhibit neuroprotective effects.

Latest Patents

Richard H Himes holds a patent for neuroprotective agents, specifically novel stereoisomers of GS-164. The compounds he developed, such as (3R,5S,7as)-(3,5-bis(4-fluorophenyl)tetrahydro-1H-oxazolo[3,4-c]oxazol-7a-yl)methanol (TH-237A) and (3R,5S,7as)-(3,5-bis(4-fluorophenyl)tetrahydro-1H-oxazolo[3,4-c]oxazol-7a-yl)methanol (TH-242A), exhibit neuroprotective effects through mechanisms that do not involve microtubule stabilization. This innovative approach highlights his commitment to advancing medical science.

Career Highlights

Richard H Himes is affiliated with the University of Kansas, where he continues to contribute to research and development in his field. His work has garnered attention for its potential applications in neuroprotection, making him a valuable asset to the academic and scientific community.

Collaborations

He has collaborated with esteemed colleagues, including Mary Louise Michaelis and Ingrid Gunda Georg. These partnerships have further enriched his research and expanded the impact of his innovations.

Conclusion

Richard H Himes is a distinguished inventor whose work in neuroprotective agents is paving the way for future advancements in medical treatments. His dedication to innovation and collaboration underscores the importance of research in improving health outcomes.